Correlation of gefitinib efficacy and detection of new EGFR mutation variants in pre-treated patients (pts) with advanced non- small cell lung cancer (NSCLC) Previous studies have shown pre and ...
Phase II study of NGR-hTNF, a vascular targeting agent, in combination with doxorubicin in patients with relapsed small cell lung cancer (SCLC). Background: Carcinoembryonic antigen (CEA, CEACAM5) is ...
Please provide your email address to receive an email when new articles are posted on . Elevated postoperative serum carcinoembryonic antigen increased risk for recurrence, especially within the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results